Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Prostate Adenocarcinoma Cancer AJCC v8”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Looking for participantsNCT04734730
What this trial is testing

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821792
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaProstate AdenocarcinomaProstate Carcinoma Metastatic in the Bone+3 more
M.D. Anderson Cancer Center 60
Very early researchStudy completedNCT04976257
What this trial is testing

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaStage IIC Prostate Cancer AJCC v8+7 more
Ryan Kohlbrenner, MD 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Looking for participantsNCT03678025
What this trial is testing

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
SWOG Cancer Research Network 1,273
Testing effectiveness (Phase 2)Ended earlyNCT03649841
What this trial is testing

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+5 more
University of Washington 10
Large-scale testing (Phase 3)Looking for participantsNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Looking for participantsNCT05960578
What this trial is testing

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaProstate AdenocarcinomaStage IV Prostate Cancer AJCC v8
University of Washington 34
Testing effectiveness (Phase 2)WithdrawnNCT03581500
What this trial is testing

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaPSA Level Greater Than TenStage IIB Prostate Cancer AJCC v8+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04050215
What this trial is testing

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Jonsson Comprehensive Cancer Center 937
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)Temporarily pausedNCT05445609
What this trial is testing

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8
Emory University 10
Early research (Phase 1)Looking for participantsNCT06942104
What this trial is testing

Imaging of Solid Tumors Using 18F-TRX

Who this might be right for
Solid TumorSolid CarcinomaCastration-Resistant Prostate Carcinoma+7 more
Rahul Aggarwal 56
Not applicableLooking for participantsNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT05113537
What this trial is testing

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+4 more
Vadim S Koshkin 30
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471974
What this trial is testing

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaMetastatic Prostate Small Cell Carcinoma+3 more
Rahul Aggarwal 61
Load More Results